Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Neurohr

Showing results (31-40 of 114) with videos related to

Pageof 12
Sort By:
American Journal of Respiratory and Critical Care Medicine|January 18, 2006
Brain natriuretic peptide is a prognostic parameter in chronic lung diseaseHanno H Leuchte, Rainer A Baumgartner, Michal El Nounou, et al.
Respiration; International Review of Thoracic Diseases|November 27, 2015
Self-Report Daily Life Activity as a Prognostic Marker of Idiopathic Pulmonary FibrosisHanno H Leuchte, Philip Mernitz, Carlos Baezner, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 6, 2023
Mechanical Power Density Predicts Prolonged Ventilation Following Double Lung TransplantationAlessandro Ghiani, Nikolaus Kneidinger, Claus Neurohr, et al.
Pulmonary Circulation|February 5, 2019
Real-life data on Selexipag for the treatment of pulmonary hypertensionMichaela Barnikel, Nikolaus Kneidinger, Friederike Klenner, et al.
Clinical Transplantation|August 1, 2013
Parameters associated with short- and midterm survival in bridging to lung transplantation with extracorporeal membrane oxygenationThomas Weig, Michael Irlbeck, Lorenz Frey, et al.
Respiratory Research|September 12, 2018
Combined diffusing capacity for nitric oxide and carbon monoxide as predictor of bronchiolitis obliterans syndrome following lung transplantationAnna Winkler, Kathrin Kahnert, Jürgen Behr, et al.
Respiration; International Review of Thoracic Diseases|August 22, 2016
Insights from the German Compassionate Use Program of Nintedanib for the Treatment of Idiopathic Pulmonary FibrosisFrancesco Bonella, Michael Kreuter, Lars Hagmeyer, et al.
The Thoracic and Cardiovascular Surgeon|December 21, 2013
Munich lung transplant group: waiting list during the first 9 months of the lung allocation score eraNikolaus Kneidinger, Hauke Winter, Alma Sisic, et al.
Journal of the American College of Cardiology|March 5, 2004
Clinical significance of brain natriuretic peptide in primary pulmonary hypertensionHanno H Leuchte, Michael Holzapfel, Rainer A Baumgartner, et al.
Scientific Reports|July 15, 2024
Mechanical power density, spontaneous breathing indexes, and prolonged weaning failure: a prospective cohort studyAlessandro Ghiani, Swenja Walcher, Azal Lutfi, et al.
Pageof 12

Showing results (31-40 of 114) with videos related to

Sort By:
Pageof 12
American Journal of Respiratory and Critical Care Medicine|January 18, 2006
Brain natriuretic peptide is a prognostic parameter in chronic lung diseaseHanno H Leuchte, Rainer A Baumgartner, Michal El Nounou, et al.
Respiration; International Review of Thoracic Diseases|November 27, 2015
Self-Report Daily Life Activity as a Prognostic Marker of Idiopathic Pulmonary FibrosisHanno H Leuchte, Philip Mernitz, Carlos Baezner, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 6, 2023
Mechanical Power Density Predicts Prolonged Ventilation Following Double Lung TransplantationAlessandro Ghiani, Nikolaus Kneidinger, Claus Neurohr, et al.
Pulmonary Circulation|February 5, 2019
Real-life data on Selexipag for the treatment of pulmonary hypertensionMichaela Barnikel, Nikolaus Kneidinger, Friederike Klenner, et al.
Clinical Transplantation|August 1, 2013
Parameters associated with short- and midterm survival in bridging to lung transplantation with extracorporeal membrane oxygenationThomas Weig, Michael Irlbeck, Lorenz Frey, et al.
Respiratory Research|September 12, 2018
Combined diffusing capacity for nitric oxide and carbon monoxide as predictor of bronchiolitis obliterans syndrome following lung transplantationAnna Winkler, Kathrin Kahnert, Jürgen Behr, et al.
Respiration; International Review of Thoracic Diseases|August 22, 2016
Insights from the German Compassionate Use Program of Nintedanib for the Treatment of Idiopathic Pulmonary FibrosisFrancesco Bonella, Michael Kreuter, Lars Hagmeyer, et al.
The Thoracic and Cardiovascular Surgeon|December 21, 2013
Munich lung transplant group: waiting list during the first 9 months of the lung allocation score eraNikolaus Kneidinger, Hauke Winter, Alma Sisic, et al.
Journal of the American College of Cardiology|March 5, 2004
Clinical significance of brain natriuretic peptide in primary pulmonary hypertensionHanno H Leuchte, Michael Holzapfel, Rainer A Baumgartner, et al.
Scientific Reports|July 15, 2024
Mechanical power density, spontaneous breathing indexes, and prolonged weaning failure: a prospective cohort studyAlessandro Ghiani, Swenja Walcher, Azal Lutfi, et al.
Pageof 12